The nation of Zimbabwe has rejected a significant American healthcare agreement valued at 367 million US dollars (272 million pounds) over five years due to Washington's insistence on sensitive information.
This rejection came to light after a government memo from December was leaked, indicating that Head of State Emmerson Mnangagwa deemed the arrangement was "unbalanced".
A government spokesperson later clarified that the US was requesting genetic material for research and profit but refused to share the resulting advantages from future treatments.
"We will now turn to the challenging and unfortunate task of ending our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the United States had furnished more than $1.9bn as health assistance to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has called for further negotiations to reach a agreement suitable to both sides so the nation's critical HIV programme can be sustained.
Broader Context
Zimbabwe's decision comes after a comparable situation in Kenya, where a court suspended a similar deal with the US after legal challenges were filed about the safety of Kenyans' health data.
After returning to the presidency recently, US President Donald Trump has drastically cut overseas assistance and shut down the key foreign aid agency.
The agency had overseen aid for the American government, but Trump stated its spending was "inefficient" and his government was pursuing direct bilateral deals to boost transparency and responsibility.
According to statements, 16 African countries have to date signed similar agreements, representing more than $18.3bn in committed funds.
Details of the Declined Agreement
The funds for Zimbabwe would have supported "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this partnership could have provided significant advantages for the people of Zimbabwe, especially the 1.2 million men, women and children presently receiving HIV treatment via American-funded programmes," the Ambassador added.
However, government spokesperson Nick Mangwana said the proposed deal was "asymmetrical".
"Our nation was requested to surrender its biological resources and data over an extended period, without any equivalent assurance of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that might be developed from that provided information," his statement read.
"Put simply, our nation would provide the raw materials for scientific discovery with no certainty that the final treatments would be available to our population should a future disease outbreak arise."
National Interest and Global Health
Mangwana further noted that the US's withdrawal from the global health body and its push of bilateral health agreements were disrupting frameworks previously set up through the international organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing system created to manage potential global health emergencies.
"This mechanism is designed to guarantee that when a nation provides its data, the benefits – such as medicines and cures – are distributed fairly, not commercialised solely by those with the capability to develop them."
Zimbabwe's reservations regarding the US deal "must not be interpreted as opposition to America," Mangwana stressed.
"We are open to further dialogue with our US partners on how subsequent collaboration could be designed in a way that respects the independence and dignity of both nations."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the official position, but recommended that negotiations must proceed given that much of the nation's HIV programmes were funded by international support.
"Where technical issues exist, such as those relating to data governance or implementation frameworks, these can often be addressed via detailed discussion and mutually agreed protections," the group commented.
The situation highlights the ongoing debate between receiving crucial international aid and protecting a country's data in an increasingly data-driven world.